Skip to main content
Clinical Trials/CTRI/2018/07/014840
CTRI/2018/07/014840
Not yet recruiting
Phase 4

A Randomized Controlled Trial to assess the efficacy of Topical Besifloxacin0.6% versus Moxifloxacin0.5% in Bacterial Conjunctivitis.

C K Devipriya0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Bacterial conjunctivitis
Sponsor
C K Devipriya
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
C K Devipriya

Eligibility Criteria

Inclusion Criteria

  • 1 Age Above 18 years both male and female
  • 2 Patients who are clinically diagnosed as bacterial conjunctivitis
  • 3 Patients with visual acuity \>6/60 in both eyes
  • 4 Patients willing to give a written informed consent

Exclusion Criteria

  • 1 Patients with other form of conjunctivitis like viral or allergic conjunctivitis
  • 2 Patient already using any topical eyedrops
  • 3 Patient with any history of ocular surgery within 6 weeks of study entry
  • 4 Patients with iritis,active ulcerative keratitis recurrent corneal erosion syndrome
  • 5 Patients with history of drug allergy

Outcomes

Primary Outcomes

Not specified

Similar Trials